The CD58-CD2 axis in cancer immune evasion by Quastel, M, Dustin, M

Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity by Li, D, Brackenridge, S, Walters, L, Harlos, K, Rozbesky, D, Quastel, M, Borrow, P, Jones, EY, Gillespie, G, McMichael, A

Identification and structural characterization of a mutant KRAS‐G12V specific TCR restricted by HLA‐A3 by Sim, MJW, Hanada, K, Stotz, Z, Yu, Z, Lu, J, Brennan, P, Quastel, M, Gillespie, GM, Long, EO, Yang, JC, Sun, PD

Primary and secondary functions of HLA-E are determined by stability and conformation of the peptide-bound complexes by Walters, LC, Rozbesky, D, Harlos, K, Quastel, M, Sun, H, Springer, S, Rambo, RP, Mohammed, F, Jones, EY, McMichael, AJ, Gillespie, GM

The role and uses of antibodies in COVID-19 infections: a living review by Scourfield, DO, Reed, SG, Quastel, M, Alderson, J, Bart, VMT, Teijeira Crespo, A, Jones, R, Pring, E, Richter, FC, Issa, FG, Burnell, SEA

HLA class I signal peptide polymorphism determines the level of CD94/NKG2–HLA-E-mediated regulation of effector cell responses by Lin, Z, Bashirova, AA, Viard, M, Garner, L, Quastel, M, Beiersdorfer, M, Kasprzak, WK, Akdag, M, Yuki, Y, Ojeda, P, Das, S, Andresson, T, Naranbhai, V, Horowitz, A, McMichael, AJ, Hoelzemer, A, Gillespie, GM, Garcia-Beltran, WF, Carrington, M

HLA-E-restricted SARS-CoV-2-specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation by Yang, H, Sun, H, Brackenridge, S, Zhuang, X, Wing, PAC, Quastel, M, Walters, L, Garner, L, Wang, B, Yao, X, Felce, SL, Peng, Y, Moore, S, Peeters, BWA, Rei, M, Canto Gomes, J, Tomas, A, Davidson, A, Semple, MG, Turtle, LCW, Openshaw, PJM, Baillie, JK, Mentzer, AJ, Klenerman, P, ISARIC4C Investigators, Borrow, P, Dong, T, McKeating, JA, Gillespie, GM, McMichael, AJ